Calcified Tissue International

, Volume 104, Issue 3, pp 273–284 | Cite as

Association Between the Decline in Muscle Health and the Decline in Bone Health in Older Individuals from the SarcoPhAge Cohort

  • Médéa LocquetEmail author
  • Charlotte Beaudart
  • Jean-Yves Reginster
  • Olivier Bruyère
Original Research


The longitudinal relationship between bone health and muscle health is scarcely explored. We aimed to explore the relationship between bone decline and muscle decline over 1 year in older individuals. We used data from the SarcoPhAge cohort, which aims to identify the consequences of sarcopenia. In this way, this study also highlights the yearly changes in muscle mass (by dual-energy absorptiometry), muscle weakness (by grip strength), and/or physical performance (by the short physical performance battery test). Measurements of areal bone mineral density (aBMD), enabling the diagnosis of osteoporosis, and bone microarchitecture (by means of the trabecular bone score) were also performed each year. A 1-year clinically relevant decline in bone and muscle health components was evidenced using the Edwards–Nunnally index. Among the 232 participants with complete data (75.5 ± 5.4 years, 57.8% women), we observed an association between a clinically relevant decline in the skeletal muscle mass index (SMI) and a decrease in aBMD (adjusted OR = 2.12 [1.14–2.51] for the spine, 2.42 [1.10–5.34] for the hip and 2.12 [1.04–5.81] for the neck), as well as a significant association between SMI and deterioration of the skeletal microarchitecture (aOR = 3.99 [2.07–7.70]). A clinically relevant decline in muscle strength was associated with a decrease in spine aBMD (aOR = 2.93 [1.21–7.12]) and hip aBMD (aOR = 3.42 [1.37–7.64]) only. The decline in muscle performance was related to the decline in bone microarchitecture only (aOR = 2.52 [1.23–5.17]). Individuals with incident sarcopenia had an approximately fivefold higher risk of concomitantly developing osteoporosis. A dynamic relationship between impaired muscle and bone health was observed, with an obvious association between the concomitant incidences of osteoporosis and sarcopenia.


Sarcopenia Osteoporosis Follow-up SarcoPhAge study Muscle strength Physical performance 


Compliance with Ethical Standards

Conflict of interest

Médéa Locquet, Charlotte Beaudart, Jean-Yves Reginster, and Olivier Bruyère declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

The study protocol and related amendments received approval from the competent ethics authority of our institution (under reference 2012/277). All procedures were in accordance with the 1964 Helsinki declaration and its later amendments. Prior to the collection of baseline measurements and at each additional test added, the participants were rigorously informed about the study objectives and procedures, after which they provided informed written consent to the protocol itself and its amendments.

Supplementary material

223_2018_503_MOESM1_ESM.docx (26 kb)
Supplementary material 1 (DOCX 26 KB)


  1. 1.
    Cianferotti L, Brandi ML (2014) Muscle–bone interactions: basic and clinical aspects. Endocrine 45:165–177. CrossRefGoogle Scholar
  2. 2.
    Gielen E, Bergmann P, Bruyère O et al (2017) Osteoporosis in frail patients: a consensus paper of the Belgian bone club. Calcif Tissue Int. Google Scholar
  3. 3.
    Reginster J-Y, Burlet N (2006) Osteoporosis: a still increasing prevalence. Bone 38:4–9. CrossRefGoogle Scholar
  4. 4.
    Ethgen O, Beaudart C, Buckinx F et al (2017) The future prevalence of sarcopenia in Europe: a claim for public health action. Calcif Tissue Int 100:229–234. CrossRefGoogle Scholar
  5. 5.
    Bruyère O, Beaudart C, Locquet M et al (2016) Sarcopenia as a public health problem. Eur Geriatr Med. Google Scholar
  6. 6.
    Kanis JA, McCloskey EV, Harvey NC et al (2015) Intervention thresholds and the diagnosis of osteoporosis. J Bone Miner Res 30:1747–1753. CrossRefGoogle Scholar
  7. 7.
    Kanis JA, Cooper C, Rizzoli R et al (2017) Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting. Osteoporos Int 28:2023–2034. CrossRefGoogle Scholar
  8. 8.
    Cruz-Jentoft AJ, Baeyens JP, Bauer JM et al (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 39:412–423. CrossRefGoogle Scholar
  9. 9.
    Chen L-K, Liu L-K, Woo J et al (2014) Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 15:95–101. CrossRefGoogle Scholar
  10. 10.
    Studenski SA, Peters KW, Alley DE et al (2014) The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A 69:547–558. CrossRefGoogle Scholar
  11. 11.
    Morley JE, Abbatecola AM, Argiles JM et al (2011) Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc 12:403–409. CrossRefGoogle Scholar
  12. 12.
    Marzetti E, Calvani R, Tosato M et al (2017) Sarcopenia: an overview. Aging Clin Exp Res 29:11–17. CrossRefGoogle Scholar
  13. 13.
    Locquet M, Beaudart C, Reginster J-Y et al (2017) Prevalence of concomitant bone and muscle wasting in elderly women from the SarcoPhAge cohort: preliminary results. J Frailty Aging 6:18–23. Google Scholar
  14. 14.
    Paintin J, Cooper C, Dennison E (2018) Osteosarcopenia. Br J Hosp Med 79:253–258. CrossRefGoogle Scholar
  15. 15.
    Hirschfeld HP, Kinsella R, Duque G (2017) Osteosarcopenia: where bone, muscle, and fat collide. Osteoporos Int 28:2781–2790. CrossRefGoogle Scholar
  16. 16.
    Locquet M, Beaudart C, Bruyère O et al (2018) Bone health assessment in older people with or without muscle health impairment. Osteoporos Int 29:1057–1067. CrossRefGoogle Scholar
  17. 17.
    Tarantino U, Baldi J, Celi M et al (2013) Osteoporosis and sarcopenia: the connections. Aging Clin Exp Res 25:93–95. CrossRefGoogle Scholar
  18. 18.
    Beaudart C, Reginster JY, Petermans J et al (2015) Quality of life and physical components linked to sarcopenia: the SarcoPhAge study. Exp Gerontol 69:103–110. CrossRefGoogle Scholar
  19. 19.
    Roberts HC, Denison HJ, Martin HJ et al (2011) A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. Age Ageing 40:423–429. CrossRefGoogle Scholar
  20. 20.
    Guralnik JM, Ferrucci L, Pieper CF et al (2000) Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery. J Gerontol A 55:M221–M231CrossRefGoogle Scholar
  21. 21.
    Wright NC, Looker AC, Saag KG et al (2014) The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine. J Bone Miner Res 29:2520–2526. CrossRefGoogle Scholar
  22. 22.
    Harvey NC, Glüer CC, Binkley N et al (2015) Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice. Bone 78:216–224. CrossRefGoogle Scholar
  23. 23.
    Johansson H, Kanis JA, McCloskey EV et al (2011) A FRAX® model for the assessment of fracture probability in Belgium. Osteoporos Int 22:453–461. CrossRefGoogle Scholar
  24. 24.
    Guigoz Y, Vellas B, Garry PJ (2009) Assessing the nutritional status of the elderly: the Mini Nutritional Assessment as part of the geriatric evaluation. Nutr Rev 54:S59–S65. CrossRefGoogle Scholar
  25. 25.
    Tombaugh TN, McIntyre NJ (1992) The mini-mental state examination: a comprehensive review. J Am Geriatr Soc 40:922–935CrossRefGoogle Scholar
  26. 26.
    Elosua R, Marrugat J, Molina L et al (1994) Validation of the Minnesota leisure time physical activity questionnaire in Spanish men. Am J Epidemiol 139:1197–1209. CrossRefGoogle Scholar
  27. 27.
    Speer DC (1992) Clinically significant change: Jacobson and Truax (1991) revisited. J Consult Clin Psychol 60:402–408CrossRefGoogle Scholar
  28. 28.
    Lodder MC, Lems WF, Ader HJ et al (2004) Reproducibility of bone mineral density measurement in daily practice. Ann Rheum Dis 63:285–289. CrossRefGoogle Scholar
  29. 29.
    Imerci A, Yalın Kılınç C, Aydogan NH et al (2017) Fracture Risk Assessment tool (FRAX®) results calculated with and without bone mineral density values for the evaluation of fracture risk in postmenopausal women with osteopenia. J Clin Densitom. Google Scholar
  30. 30.
    Moreira OC, Oliveira CEP de, De Paz JA (2018) Dual energy X-ray absorptiometry (DXA) reliability and intraobserver reproducibility for segmental body composition measuring. Nutr Hosp 35:340–345. Google Scholar
  31. 31.
    Savva C, Giakas G, Efstathiou M, Karagiannis C (2014) Test-retest reliability of handgrip strength measurement using a hydraulic hand dynamometer in patients with cervical radiculopathy. J Manipulative Physiol Ther 37:206–210. CrossRefGoogle Scholar
  32. 32.
    Gómez JF, Curcio C-L, Alvarado B et al (2013) Validity and reliability of the short physical performance battery (SPPB): a pilot study on mobility in the Colombian Andes. Colomb Med 44:165–171Google Scholar
  33. 33.
    Kim KM, Lim S, Oh TJ et al (2018) Longitudinal changes in muscle mass and strength, and bone mass in older adults: gender-specific associations between muscle and bone losses. J Gerontol A 73:1062–1069. CrossRefGoogle Scholar
  34. 34.
    Kwon S, Perera S, Pahor M et al (2009) What is a meaningful change in physical performance? Findings from a clinical trial in older adults (the LIFE-P study). J Nutr Health Aging 13:538–544CrossRefGoogle Scholar
  35. 35.
    Hans D, Goertzen AL, Krieg M-A, Leslie WD (2011) Bone microarchitecture assessed by TBS predicts osteoporotic fractures independent of bone density: the Manitoba study. J Bone Miner Res 26:2762–2769. CrossRefGoogle Scholar
  36. 36.
    Moon RJ, Cole ZA, Crozier SR et al (2015) Longitudinal changes in lean mass predict pQCT measures of tibial geometry and mineralisation at 6–7 years. Bone 75:105–110. CrossRefGoogle Scholar
  37. 37.
    Elkasrawy MN, Hamrick MW (2010) Myostatin (GDF-8) as a key factor linking muscle mass and bone structure. J Musculoskelet Neuronal Interact 10:56–63Google Scholar
  38. 38.
    Yeung SSY, Reijnierse EM, Trappenburg MC et al (2018) Handgrip strength cannot be assumed a proxy for overall muscle strength. J Am Med Dir Assoc 19:703–709. CrossRefGoogle Scholar
  39. 39.
    Harvey NC, Odén A, Orwoll E et al (2018) Measures of physical performance and muscle strength as predictors of fracture risk independent of FRAX, falls and BMD: a meta-analysis of the Osteoporotic Fractures in Men (MrOS) study. J Bone Miner Res. Google Scholar
  40. 40.
    Russo CR, MD (2009) The effects of exercise on bone. Basic concepts and implications for the prevention of fractures. Clin Cases Miner Bone Metab 6:223–228Google Scholar
  41. 41.
    Wagner P, Chapurlat R, Ecochard R, Szulc P (2018) Low muscle strength and mass is associated with the accelerated decline of bone microarchitecture at the distal radius in older men: the prospective STRAMBO study. J Bone Miner Res. Google Scholar
  42. 42.
    Khazzani H, Allali F, Bennani L et al (2009) The relationship between physical performance measures, bone mineral density, falls, and the risk of peripheral fracture: a cross-sectional analysis. BMC Public Health 9:297. CrossRefGoogle Scholar
  43. 43.
    Nielsen BR, Abdulla J, Andersen HE et al (2018) Sarcopenia and osteoporosis in older people: a systematic review and meta-analysis. Eur Geriatr Med 9:419–434. CrossRefGoogle Scholar
  44. 44.
    Picca A, Calvani R, Manes-Gravina E et al (2018) Bone-muscle crosstalk: unraveling new therapeutic targets for osteoporosis. Curr Pharm Des 23:6256–6263. CrossRefGoogle Scholar
  45. 45.
    Reginster J-Y, Beaudart C, Buckinx F, Bruyère O (2016) Osteoporosis and sarcopenia: two diseases or one? Curr Opin Clin Nutr Metab Care 19:31–36. CrossRefGoogle Scholar
  46. 46.
    Karsenty G, Ferron M (2012) The contribution of bone to whole-organism physiology. Nature 481:314–320. CrossRefGoogle Scholar
  47. 47.
    Tagliaferri C, Wittrant Y, Davicco M-J et al (2015) Muscle and bone, two interconnected tissues. Ageing Res Rev 21:55–70. CrossRefGoogle Scholar
  48. 48.
    Lam H, Qin Y-X (2008) The effects of frequency-dependent dynamic muscle stimulation on inhibition of trabecular bone loss in a disuse model. Bone. Google Scholar
  49. 49.
    Bonnick SL (2008) Monitoring changes in bone density. Women’s Health 4:89–97. CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Médéa Locquet
    • 1
    Email author
  • Charlotte Beaudart
    • 1
  • Jean-Yves Reginster
    • 1
    • 2
  • Olivier Bruyère
    • 1
  1. 1.World Health Organization Collaborating Center for the Public Health Aspects of Musculoskeletal Health and Aging, Department of Public Health Sciences, Epidemiology and Health EconomicsUniversity of LiègeLiègeBelgium
  2. 2.Chair for Biomarkers of Osteoporosis, Biochemistry Department, College of ScienceKing Saud UniversityRiyadhKingdom of Saudi Arabia

Personalised recommendations